FDA's Accelerated Approval Program: Facts, Myths & the Perspectives of Neurologists & Neurology Care Providers

The 45-minute program includes:

  • ┬áThe history and benefits of Accelerated Approval

  • An overview of the findings of CNSA’s Clinical Awareness Initiative nationwide survey with neurologists and neurology care providers

  • A review of CNSA’s white paper discussing the conceptions, misconceptions and dispelling the myths about Accelerated Approval.

Clinical Awareness Initiative Project Advisors:

The webinar discussion will be led by two members of the advisory panel who oversaw the development of CNSA’s Clinical Awareness Initiative project – David Charles, MD, chair of the advisory panel, and Nina Riggins, MD, PhD.

David Charles, MD – Chair

Nina Riggins, MD, PhD

Moderated By:

  • Michelle Winokur, DrPH – Executive Director, CNSA

To read CNSA’s survey report “Accelerated Drug Approval,” click here. To read the accompanying white paper, click here. To learn more about the Clinical Awareness Initiative, click here.